Endocrine-disrupting chemicals found in everyday plastics, food packaging, and personal care products measurably affect fat cell development, thyroid function, and insulin signaling — contributing to obesity independently of caloric intake.
Emotional eating is driven by neurobiological mechanisms — not weak character. Stress activates dopamine and opioid reward pathways that prioritize high-calorie food seeking in ways that override prefrontal inhibitory control. Understanding the neuroscience changes how to address it.
East Asian populations develop metabolic syndrome and type 2 diabetes at lower BMIs than Western populations — driven by a distinct body composition pattern of higher visceral fat and lower muscle mass at equivalent body weight. Taiwan's metabolic disease burden reflects this phenotype.
Chronically elevated blood sugar damages the kidneys, eyes, nerves, and blood vessels through mechanisms that begin long before a diabetes diagnosis. This article explains the progressive organ damage pathways and why early intervention matters.
CNFCD's methodology draws on published research from leading medical journals on insulin resistance, gut microbiome, circadian biology, and metabolic adaptation. This article explains the scientific foundations that support each component of the CNFCD approach.
JOY123 is a structured gut health protocol used within the CNFCD system. This article explains its three-step mechanism — cleanse, seed, and repair — and the metabolic science behind each phase.
The citric acid cycle (TCA cycle) is the central metabolic hub where fat-derived carbons are oxidized to produce ATP. Understanding how the TCA cycle works — and what disrupts it — explains why some people burn fat efficiently and others don't.
Every cell in the body has a biological clock synchronized to the 24-hour light-dark cycle. When these clocks are aligned with eating patterns, metabolism is efficient. When they're misaligned, metabolic dysfunction follows — independent of what's being eaten.
Adverse childhood experiences (ACEs) reprogram the HPA axis, epigenome, and immune system in ways that increase lifetime risk of metabolic syndrome, diabetes, and cardiovascular disease — independent of adult lifestyle factors.